
Neurology News Network for the week ending June 13, 2020.
Neurology News Network for the week ending June 13, 2020.
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 12, 2020.
Despite the likelihood of women receiving IV thrombolysis still being 13% lower than men, the gap narrowed by 17% from 2008 to 2018 compared to what was observed from 2000 to 2008.
Effectively addressing vascular risk factors could provide an important avenue for modifying white matter hyperintensity disease burden.
Results of the Jackson Heart Study suggest that cigarette smoking is linked with a dose-dependent higher risk of all stroke in black individuals compared to those who did not smoke.
The study confirmed previous study findings that indicated potential severe conditions such as stroke or inflammatory diseases can appear in later stages of COVID-19, including during recovery.
Coutinho et al. noted that future studies that feature a larger population will help to better determine recovery rates after endovascular treatment.
Approximately one-fourth of the excess cases of maternal stroke associated with migraine were attributable to hypertensive disorders.
Neurology News Network for the week ending June 6, 2020.
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 5, 2020.
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Shadi Yaghi, MD.
The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone shares his reaction to data that has been published and what needs to be researched going forward.
This is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in patients who have a high cardiovascular event risk, but without a history of heart attack or stroke.
Patients with acute large ischemic and hemorrhage stroke had much higher mortality risk adjusted for age.
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 29, 2020.
The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone gives perspective on his recent study of patients with stroke and COVID-19 and the difficulties in understanding their relationship.
The professor of neurology at NYU Langone shares her thoughts on the clinical data that has been released so far on patients with COVID-19.
Neurology News Network for the week ending May 23, 2020.
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 22, 2020.
Compared to those with normal fasting glucose levels, those with Type 2 diabetes had poorer cognitive performance at 3 and 6 months after suffering a stroke, based on data from the STROKOG consortium.
During the COVID-19 pandemic, it is more important than ever to ensure that a patient with stroke is transferred to the right hospital the first time around.
Neurology News Network for the week ending May 16, 2020.
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 15, 2020.
Evidence continues to increase on the neurological impacts of COVID-19 infection, with patients admitted to the intensive care unit (ICU) showing brain abnormalities on MRI scans.
Pharmazz, the developer of the endothelin-B receptor agonist, noted that it plans to move forward with an investigational new drug submission to the FDA for sovateltide.